A Health Economic Trial in Adult Patients Undergoing Laparoscopic Colectomy

PHASE4TerminatedINTERVENTIONAL
Enrollment

122

Participants

Timeline

Start Date

December 31, 2011

Primary Completion Date

September 30, 2012

Study Completion Date

February 28, 2013

Conditions
Bowel Obstruction
Interventions
DRUG

IV morphine sulfate or Sponsor-approved equivalent

Patients in this group will receive IV morphine sulfate or Sponsor-approved equivalent via a patient-controlled analgesia (PCA) pump, as needed. The PCA pump will be set up postsurgically as soon as possible and prior to the patient leaving the post-anesthesia care unit (PACU) or immediately upon transfer to a floor if the stay in the PACU is less than one hour.

DRUG

EXPAREL

"Patients will receive 266 mg EXPAREL diluted with preservative-free 0.9% normal saline to a total volume of 40 cc administered via wound infiltration prior to wound closure. When not contraindicated, 30 mg IV ketorolac will be given at the end of surgery. If not indicated, an IV non-steroidal anti-inflammatory drug (NSAID) may be substituted per the site's standard of care.~All patients will be offered rescue analgesia, as needed."

Trial Locations (6)

12208

Albany Medical College, Albany

20010

Washington Hospital Center, Washington D.C.

33136

University of Miami, Dept. Anesthesiology, Miami

33606

Tampa General Hospital, Tampa

43210

The Ohio State University Medical Center, Columbus

77030

Methodist Hospital, Houston

Sponsors
All Listed Sponsors
collaborator

Registrat-Mapi

OTHER

lead

Pacira Pharmaceuticals, Inc

INDUSTRY